Arcturus Therapeutics Holdings (ARCT) Stock
Arcturus Therapeutics Holdings (ARCT) closed at $8.31 on Nov 16, 2026; its Tenet Score is 61 of 100 against 417 Healthcare peers.
Key stats
- Previous close
- $8.31
- Nov 16, 2026
- Market cap
- $239.5M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- Dividend yield
- 0.00%
- reinvests all
- Tenet Score
- 61/100
- Solid · 417 Healthcare peers
Industry: Drugs · see every company filed here →
Arcturus Therapeutics Holdings Inc. scores 61/100. Solid. Strongest on value and financial health, quality is the soft spot versus 417 Healthcare peers.
Tenet Score · vs sector
n=417Factor grades
Momentum omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- — Munger Compounders
- — Magic Formula
No dividend. Cash stays in the business.
13F flows & insider trades land here.
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for…
Common questions
What sector and industry is Arcturus Therapeutics Holdings in?
Arcturus Therapeutics Holdings is in the Healthcare sector and the Drugs industry.
What is Arcturus Therapeutics Holdings' Tenet Score?
Arcturus Therapeutics Holdings' Tenet Score is 61 out of 100, ranked against 417 Healthcare peers as of Nov 17, 2026.




